Michael E. Cobble
Impact in
-
- Diabetes Treatment and Management
- Diabetes Management and Research
- Diabetes, Cardiovascular Risks, and Lipoproteins
-
- Cardiovascular Health and Disease Prevention
Papers in
-
- Diabetes Treatment and Management 10
- Diabetes Management and Research 4
- Diabetes, Cardiovascular Risks, and Lipoproteins 2
- Co-authors
- Robert FrederichNorman E. LeporJanani RangaswamiPeter A. McCulloughAaron Y. KlugerKristen M. TecsonAndy LeeEdgar V. Lerma
- Journals
- Cardiovascular Diabetology (2 papers)The EPMA Journal (1 paper)Diabetology & Metabolic Syndrome (1 paper)Contemporary Clinical Trials (1 paper)Reviews in Cardiovascular Medicine (1 paper)
- Partner nations
- United StatesBrazilJapan
In The Last Decade
Michael E. Cobble
19 papers receiving 480 citations
Peers
Comparison fields: 5 of 74
- Endocrinology, Diabetes and Metabolism 319
- Cardiology and Cardiovascular Medicine 129
- Nephrology 27
- Surgery 149
- Pharmacology 35
Countries citing papers authored by Michael E. Cobble
This map shows the geographic impact of Michael E. Cobble's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael E. Cobble with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael E. Cobble more than expected).
Fields of papers citing papers by Michael E. Cobble
This network shows the impact of papers produced by Michael E. Cobble. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael E. Cobble. The network helps show where Michael E. Cobble may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Michael E. Cobble, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 16 | |
| 2 | 2019 | 109 | |
| 3 | 2019 | 28 | |
| 4 | 2018 | 47 | |
| 5 | Individualizing Treatment with Statin Therapy. | 2018 | 1 |
| 6 | 2017 | 16 | |
| 7 | 2016 | 32 | |
| 8 | Coronary heart disease in women. | 2014 | 3 |
| 9 | Treatment with exenatide once weekly or twice daily for 30 weeks is associated with changes in several cardiovascular risk markers | 2012 | 6 |
| 10 | 2012 | 17 | |
| 11 | 2012 | 66 | |
| 12 | 2011 | 41 | |
| 13 | 2010 | 86 | |
| 14 | Safety, tolerability, and nonglycemic effects of incretin-based therapies | 2010 | 3 |
| 15 | Pathophysiology of type 2 diabetes mellitus: Potential role of incretin-based therapies | 2010 | 3 |
| 16 | Glucose-lowering effects of incretin-based therapies | 2010 | 2 |
| 17 | 2009 | 8 | |
| 18 | Clinical practice in type 2 diabetes: After metformin and lifestyle, then what? | 2009 | 13 |
| 19 | How to implement incretin therapy. | 2008 | 6 |
About Michael E. Cobble
Michael E. Cobble is a scholar working on Endocrinology, Diabetes and Metabolism, Geriatrics and Gerontology, Cardiology and Cardiovascular Medicine, Nephrology and Surgery, having authored 19 papers that have together received 503 indexed citations. Recurring topics across this work include Diabetes Treatment and Management (10 papers), Lipoproteins and Cardiovascular Health (4 papers), Diabetes Management and Research (4 papers), Metabolism, Diabetes, and Cancer (3 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers), Peptidase Inhibition and Analysis (2 papers), Vitamin D Research Studies (2 papers) and Cardiovascular Function and Risk Factors (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (319 citations), Cardiology and Cardiovascular Medicine (129 citations), Nephrology (27 citations), Surgery (149 citations) and Pharmacology (35 citations). Michael E. Cobble has collaborated with scholars based in United States, Brazil and Japan. Frequent co-authors include Robert Frederich, Norman E. Lepor, Janani Rangaswami, Peter A. McCullough, Aaron Y. Kluger, Kristen M. Tecson, Andy Lee, Edgar V. Lerma, Robert L. Wolfert and Anne L. Peters. Their work appears in journals such as Cardiovascular Diabetology, The EPMA Journal, Diabetology & Metabolic Syndrome, Contemporary Clinical Trials and Reviews in Cardiovascular Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.